Re: "ZHCLF" TRADING

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: "ZHCLF" TRADING

in response to

Re: "ZHCLF" TRADING

Cottenmouth

posted on Oct 21, 2021 11:31AM

I believe KBC pointed this out before.

"The status of these OTC stocks can change as they comply with the reporting requirement rule"

It would seem that ZCC ( Don ) is not complying with the "reporting requirement rule" perhaps to discourage trading of "ZHCLF".